Logo image of IONM

ASSURE HOLDINGS CORP (IONM) Stock Fundamental Analysis

NASDAQ:IONM - Nasdaq - US04625J3032 - Common Stock - Currency: USD

2.43  -0.32 (-11.64%)

After market: 1.85 -0.58 (-23.87%)

Fundamental Rating

2

Overall IONM gets a fundamental rating of 2 out of 10. We evaluated IONM against 105 industry peers in the Health Care Providers & Services industry. IONM may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, IONM is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

IONM had negative earnings in the past year.
IONM had a negative operating cash flow in the past year.
In multiple years IONM reported negative net income over the last 5 years.
In the past 5 years IONM always reported negative operating cash flow.
IONM Yearly Net Income VS EBIT VS OCF VS FCFIONM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 -10M -20M -30M

1.2 Ratios

With a Return On Assets value of -251.76%, IONM is not doing good in the industry: 96.55% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -251.76%
ROE N/A
ROIC N/A
ROA(3y)-58.19%
ROA(5y)-30.71%
ROE(3y)-212.76%
ROE(5y)-111.27%
ROIC(3y)N/A
ROIC(5y)N/A
IONM Yearly ROA, ROE, ROICIONM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 -200 -400

1.3 Margins

IONM does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IONM Yearly Profit, Operating, Gross MarginsIONM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 -100 -200 -300 -400

More info and screens

2

2. Health

2.1 Basic Checks

IONM does not have a ROIC to compare to the WACC, probably because it is not profitable.
IONM has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, IONM has a worse debt to assets ratio.
IONM Yearly Shares OutstandingIONM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 200K 400K 600K 800K 1M
IONM Yearly Total Debt VS Total AssetsIONM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M

2.2 Solvency

IONM has an Altman-Z score of -11.27. This is a bad value and indicates that IONM is not financially healthy and even has some risk of bankruptcy.
IONM has a Altman-Z score of -11.27. This is amonst the worse of the industry: IONM underperforms 89.66% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -11.27
ROIC/WACCN/A
WACC8.41%
IONM Yearly LT Debt VS Equity VS FCFIONM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 10M -10M 20M

2.3 Liquidity

IONM has a Current Ratio of 1.50. This is a normal value and indicates that IONM is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of IONM (1.50) is comparable to the rest of the industry.
A Quick Ratio of 1.50 indicates that IONM should not have too much problems paying its short term obligations.
IONM's Quick ratio of 1.50 is fine compared to the rest of the industry. IONM outperforms 60.34% of its industry peers.
Industry RankSector Rank
Current Ratio 1.5
Quick Ratio 1.5
IONM Yearly Current Assets VS Current LiabilitesIONM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for IONM have decreased strongly by -6836.67% in the last year.
The Revenue for IONM has decreased by -62.38% in the past year. This is quite bad
Measured over the past years, IONM shows a decrease in Revenue. The Revenue has been decreasing by -7.02% on average per year.
EPS 1Y (TTM)-6836.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%83.62%
Revenue 1Y (TTM)-62.38%
Revenue growth 3Y-14.76%
Revenue growth 5Y-7.02%
Sales Q2Q%-99.72%

3.2 Future

The Earnings Per Share is expected to grow by 24.90% on average over the next years. This is a very strong growth
Based on estimates for the next years, IONM will show a very strong growth in Revenue. The Revenue will grow by 35.16% on average per year.
EPS Next Y95.91%
EPS Next 2Y41.18%
EPS Next 3Y24.9%
EPS Next 5YN/A
Revenue Next Year13.65%
Revenue Next 2Y26.35%
Revenue Next 3Y35.16%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
IONM Yearly Revenue VS EstimatesIONM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
IONM Yearly EPS VS EstimatesIONM Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 -200 -400 -600

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

IONM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year IONM is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IONM Price Earnings VS Forward Price EarningsIONM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IONM Per share dataIONM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -10 -20 -30 -40

4.3 Compensation for Growth

IONM's earnings are expected to grow with 24.90% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.18%
EPS Next 3Y24.9%

More info and screens

0

5. Dividend

5.1 Amount

IONM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ASSURE HOLDINGS CORP

NASDAQ:IONM (7/23/2024, 8:17:36 PM)

After market: 1.85 -0.58 (-23.87%)

2.43

-0.32 (-11.64%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)06-07 2024-06-07/amc
Earnings (Next)08-12 2024-08-12/amc
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners126.89%
Ins Owner Change0%
Market Cap1.43M
Analysts82.86
Price Target4.08 (67.9%)
Short Float %0.02%
Short Ratio0
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-210.59%
Min EPS beat(2)-435.95%
Max EPS beat(2)14.77%
EPS beat(4)1
Avg EPS beat(4)-601.37%
Min EPS beat(4)-1923.47%
Max EPS beat(4)14.77%
EPS beat(8)1
Avg EPS beat(8)-334.84%
EPS beat(12)2
Avg EPS beat(12)-279.28%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-77.49%
Min Revenue beat(2)-84.04%
Max Revenue beat(2)-70.94%
Revenue beat(4)0
Avg Revenue beat(4)-73.34%
Min Revenue beat(4)-122.72%
Max Revenue beat(4)-15.67%
Revenue beat(8)1
Avg Revenue beat(8)-51.15%
Revenue beat(12)3
Avg Revenue beat(12)-32.93%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.4
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-41.62
EYN/A
EPS(NY)-0.29
Fwd EYN/A
FCF(TTM)-12.95
FCFYN/A
OCF(TTM)-12.86
OCFYN/A
SpS6.05
BVpS-10.29
TBVpS-10.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -251.76%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-58.19%
ROA(5y)-30.71%
ROE(3y)-212.76%
ROE(5y)-111.27%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.23
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.5
Quick Ratio 1.5
Altman-Z -11.27
F-Score1
WACC8.41%
ROIC/WACCN/A
Cap/Depr(3y)11.22%
Cap/Depr(5y)23.22%
Cap/Sales(3y)3.27%
Cap/Sales(5y)2.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-6836.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%83.62%
EPS Next Y95.91%
EPS Next 2Y41.18%
EPS Next 3Y24.9%
EPS Next 5YN/A
Revenue 1Y (TTM)-62.38%
Revenue growth 3Y-14.76%
Revenue growth 5Y-7.02%
Sales Q2Q%-99.72%
Revenue Next Year13.65%
Revenue Next 2Y26.35%
Revenue Next 3Y35.16%
Revenue Next 5YN/A
EBIT growth 1Y-156.19%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year76.04%
EBIT Next 3Y32.63%
EBIT Next 5YN/A
FCF growth 1Y25.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y24.35%
OCF growth 3YN/A
OCF growth 5YN/A